Cargando…
Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy
Port-wine birthmark (PWB) are congenital vascular malformations that commonly occur on the face and neck, with an incidence of 0.3–0.5% in the general population, causing significant negative psychological effects and economic burden to patients. Nevertheless, amidst the plethora of different treatm...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315137/ https://www.ncbi.nlm.nih.gov/pubmed/37404369 http://dx.doi.org/10.2147/CCID.S418019 |
_version_ | 1785067452257796096 |
---|---|
author | Liu, Xu Yang, Lihua Zhang, Qian Yang, Fengjuan Jiang, Xian |
author_facet | Liu, Xu Yang, Lihua Zhang, Qian Yang, Fengjuan Jiang, Xian |
author_sort | Liu, Xu |
collection | PubMed |
description | Port-wine birthmark (PWB) are congenital vascular malformations that commonly occur on the face and neck, with an incidence of 0.3–0.5% in the general population, causing significant negative psychological effects and economic burden to patients. Nevertheless, amidst the plethora of different treatment methods for PWB, choosing the option that best suits the patient’s need can be a challenge. In recent years, traditional treatment methods for PWB have been replaced by new therapies, and radioactive nuclide patch therapy is one of them. A panel of experts sought to describe herein 4 clinical cases, illustrating the PDT can demonstrate good precision and efficacy in the treatment of PWB. The research findings show the 4 patients in this group had a history of treatment with radioactive isotope patches. After 2–3 sessions of HMME-PDT, all cases achieved satisfactory results, the color of the red skin lesions significantly faded, and the area of the lesions decreased noticeably. Superficial tissue ultrasound showed a reduction in lesion thickness before and after treatment. In summary, for cases where the efficacy of PWB treatment with radioactive isotope patches is inadequate, Photodynamic therapy (PDT) can be used as a treatment reference. |
format | Online Article Text |
id | pubmed-10315137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103151372023-07-03 Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy Liu, Xu Yang, Lihua Zhang, Qian Yang, Fengjuan Jiang, Xian Clin Cosmet Investig Dermatol Case Series Port-wine birthmark (PWB) are congenital vascular malformations that commonly occur on the face and neck, with an incidence of 0.3–0.5% in the general population, causing significant negative psychological effects and economic burden to patients. Nevertheless, amidst the plethora of different treatment methods for PWB, choosing the option that best suits the patient’s need can be a challenge. In recent years, traditional treatment methods for PWB have been replaced by new therapies, and radioactive nuclide patch therapy is one of them. A panel of experts sought to describe herein 4 clinical cases, illustrating the PDT can demonstrate good precision and efficacy in the treatment of PWB. The research findings show the 4 patients in this group had a history of treatment with radioactive isotope patches. After 2–3 sessions of HMME-PDT, all cases achieved satisfactory results, the color of the red skin lesions significantly faded, and the area of the lesions decreased noticeably. Superficial tissue ultrasound showed a reduction in lesion thickness before and after treatment. In summary, for cases where the efficacy of PWB treatment with radioactive isotope patches is inadequate, Photodynamic therapy (PDT) can be used as a treatment reference. Dove 2023-06-28 /pmc/articles/PMC10315137/ /pubmed/37404369 http://dx.doi.org/10.2147/CCID.S418019 Text en © 2023 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Case Series Liu, Xu Yang, Lihua Zhang, Qian Yang, Fengjuan Jiang, Xian Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy |
title | Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy |
title_full | Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy |
title_fullStr | Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy |
title_full_unstemmed | Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy |
title_short | Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy |
title_sort | four cases of port-wine birthmark treated with hematoporphyrin monomethyl ether-mediated photodynamic therapy after radioactive nuclide patch therapy |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315137/ https://www.ncbi.nlm.nih.gov/pubmed/37404369 http://dx.doi.org/10.2147/CCID.S418019 |
work_keys_str_mv | AT liuxu fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy AT yanglihua fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy AT zhangqian fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy AT yangfengjuan fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy AT jiangxian fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy |